Dr Ademola Oyekan consultant radiation and clinical oncologist at the Lagos State University (LASUTH) speaks with Gboyega Alaka on Prostate cancer, why it is rampant among people of black race, plus ...
Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.
Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.